Indications
Therapeutic Asset Ratings
13,145 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Niraparib
Neoplasm
GlaxoSmithKline
P2
B
(57)
Nirmatrelvir
Long COVID-19
Stanford University
P2
B
(57)
Nitroglycerin Tablets
Non-Small Cell Lung Carcinoma
Instituto Nacional de Cancerologia de Mexico
P2
B
(57)
Nivestim
Amyotrophic Lateral Sclerosis
Institute of Hematology & Blood Diseases Hospital, China
P2
B
(57)
Nivestim
Dyskeratosis Congenita
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(57)
Nivestim
Lymphoproliferative Syndrome
National Cancer Institute (NCI)
P2
B
(57)
Nivolumab
Biliary Tract Cancer
Olivia Newton-John Cancer Research Institute
P2
B
(57)
Nivolumab
Gallbladder Carcinoma
National Cancer Institute (NCI)
P2
B
(57)
Nivolumab
Gallbladder Cancer
Instituto do Cancer do Estado de São Paulo
P2
B
(57)
Nivolumab
Head And Neck Neoplasm
Fred Hutchinson Cancer Center
P2
B
(57)
Nivolumab
Hepatoblastoma
Instituto do Cancer do Estado de São Paulo
P2
B
(57)
Nivolumab
Lung Large Cell Carcinoma
M.D. Anderson Cancer Center
P2
B
(57)
Nivolumab
Neuroendocrine Neoplasm
Instituto do Cancer do Estado de São Paulo
P2
B
(57)
Nivolumab
Penile Neoplasm
Instituto do Cancer do Estado de São Paulo
P2
B
(57)
Nivolumab
Wilms Tumor
Children's National Research Institute
P2
B
(57)
NKT2152
Nonpapillary Renal Cell Carcinoma
NiKang Therapeutics, Inc.
P2
B
(57)
NKT2152
Kidney Neoplasm
NiKang Therapeutics, Inc.
P2
B
(57)
NKT2152
Renal Cell Carcinoma
NiKang Therapeutics, Inc.
P2
B
(57)
nmd670
Spinal Muscular Atrophy
NMD Pharma A/S
P2
B
(57)
nnc0174-0833
Metabolic Dysfunction-Associated Steatohepatitis
Novo Nordisk A/S
P2
B
(57)
N,N-Dimethyltryptamine
Major Depressive Disorder
Universidade Federal do Rio Grande do Norte
P2
B
(57)
N,N-Dimethyltryptamine
Depressive Disorder
Universidade Federal do Rio Grande do Norte
P2
B
(57)
Nogapendekin Alfa Inbakicept
Acute Myeloid Leukemia
Masonic Cancer Center, University of Minnesota
P2
B
(57)
Nogitecan
Myelodysplastic/Myeloproliferative Neoplasm
National Cancer Institute (NCI)
P2
B
(57)
Nora520
Postpartum Depression
DuKang Pharmaceuticals, Inc.
P2
B
(57)
Showing 3301 to 3325 of 13,145 assets
Previous
Page 133 of 526
Next